NirmatrelvirRitonavirQualityChecker

Nirmatrelvir Ritonavir

antivirals API biologics dissolution essential medicines global market heavy metals impurities
Open selection

Nirmatrelvir/Ritonavir Quality Checker — Anti-COVID Combination (Ph. Eur., USP)

ℹ️ The utility checks assay and impurities of both components, solvents, dissolution profile.
ℹ️ Does not use machine learning — rule-based logic only.
️ CRITICAL! Oxidized impurities: Nirmatrelvir ≤0.5%, Ritonavir ≤1.0%. Dichloromethane ≤600 ppm!

Usage:
NirmatrelvirRitonavirQualityChecker.exe → demo mode
NirmatrelvirRitonavirQualityChecker.exe input.csv output.json → evaluate data

Input format:
BatchNumber,Nirmatrelvir_Assay_Percent,Nirmatrelvir_Oxidized_Impurity_Percent,Nirmatrelvir_Hydrolysis_Impurity_Percent,Ritonavir_Assay_Percent,Ritonavir_Oxidized_Impurity_Percent,Ritonavir_Isomer_Impurity_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Residual_Solvent_Toluene_ppm,Residual_Solvent_Dichloromethane_ppm,Residual_Solvent_Acetonitrile_ppm,Heavy_Metals_ppm,Nirmatrelvir_Dissolution_30min_Percent,Ritonavir_Dissolution_30min_Percent,Weight_Variation_RSD,Friability_Percent,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected

Example:
NIR-RIT-2026-001,100.5,0.2,0.15,101.0,0.4,0.3,1.0,0.4,150,200,100,5,85.0,80.0,2.0,0.3,20,5,0,0

— WHY IS THIS NEEDED?
Nirmatrelvir/Ritonavir combination is used for COVID-19 treatment:
• Nirmatrelvir: Main active component. Sensitive to oxidation and nitrile hydrolysis. Control of oxidized and hydrolyzed impurities is critical (≤0.5%).
• Ritonavir: Pharmacokinetic booster. Contains a thio group sensitive to oxidation and chiral centers. Impurity limits are wider (≤1.0%) but strict control is mandatory.
• Synthesis often involves toluene, dichloromethane, and acetonitrile (ICH Q3C Class 2). Limits are strict.
• Low solubility of both components makes the dissolution profile a key parameter for bioavailability.
️ CRITICAL:
• Nirmatrelvir: Assay 95–105%, Oxidation ≤0.5%, Hydrolysis ≤0.5%, Dissolution ≥80%
• Ritonavir: Assay 90–110%, Oxidation ≤1.0%, Isomers ≤1.0%, Dissolution ≥75%
• Total Impurities: ≤ 2.0%
• Dichloromethane: ≤ 600 ppm
• Heavy Metals: ≤ 10 ppm
• Microbiology: standard limits
⚠️ Note: Utility adapted for two-component system check. Deviation in any component leads to batch rejection. Oxidized impurity control is a safety priority due to toxicity risk of degradation products at high doses.

input.csv

BatchNumber,Nirmatrelvir_Assay_Percent,Nirmatrelvir_Oxidized_Impurity_Percent,Nirmatrelvir_Hydrolysis_Impurity_Percent,Ritonavir_Assay_Percent,Ritonavir_Oxidized_Impurity_Percent,Ritonavir_Isomer_Impurity_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Residual_Solvent_Toluene_ppm,Residual_Solvent_Dichloromethane_ppm,Residual_Solvent_Acetonitrile_ppm,Heavy_Metals_ppm,Nirmatrelvir_Dissolution_30min_Percent,Ritonavir_Dissolution_30min_Percent,Weight_Variation_RSD,Friability_Percent,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected
NIR-RIT-2026-001,100.5,0.2,0.15,101.0,0.4,0.3,1.0,0.4,150,200,100,5,85.0,80.0,2.0,0.3,20,5,0,0

URS & FS — user requirements and functional specification

This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.

Utility: NirmatrelvirRitonavirQualityCheckerAPI / object: Nirmatrelvir RitonavirCategory: Global API expansion

1. Scope

The Nirmatrelvir Ritonavir Quality Checker utility is used for Nirmatrelvir Ritonavir. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.

The utility does not use machine learning; decisions are produced by deterministic rules.

Categories: Global API expansion

Tags: antivirals, API, biologics, dissolution, essential medicines, global market, heavy metals, impurities, microbiology, oncology

2. Execution modes

NirmatrelvirRitonavirQualityChecker.exe                            → demo mode
NirmatrelvirRitonavirQualityChecker.exe input.csv output.json      → evaluate data

3. Key controlled areas

  • assay / content
  • purity and impurities
  • dissolution / disintegration
  • residual solvents
  • microbiology and pathogens
  • heavy metals / elemental impurities

4. Domain limits and critical parameters

  • Nirmatrelvir: Main active component. Sensitive to oxidation and nitrile hydrolysis. Control of oxidized and hydrolyzed impurities is critical (≤0.5%).
  • Ritonavir: Pharmacokinetic booster. Contains a thio group sensitive to oxidation and chiral centers. Impurity limits are wider (≤1.0%) but strict control is mandatory.
  • ️ CRITICAL:
  • Nirmatrelvir: Assay 95–105%, Oxidation ≤0.5%, Hydrolysis ≤0.5%, Dissolution ≥80%
  • Ritonavir: Assay 90–110%, Oxidation ≤1.0%, Isomers ≤1.0%, Dissolution ≥75%
  • Total Impurities: ≤ 2.0%
  • Dichloromethane: ≤ 600 ppm
  • Heavy Metals: ≤ 10 ppm
  • Microbiology: standard limits
  • ⚠️ Note: Utility adapted for two-component system check. Deviation in any component leads to batch rejection. Oxidized impurity control is a safety priority due to toxicity risk of degradation products at high doses.
Limits stated in the description must be verified against the current approved specification, pharmacopoeial monograph and registration dossier before production use.

5. URS — user requirements

IDRequirementCriticalityAcceptance criterion
URS-001The system shall accept an input.csv file for Nirmatrelvir Ritonavir with the exact columns listed in the “Input data contract” section.HighA file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error.
URS-002The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data.MediumBoth execution scenarios produce a predictable result or clear diagnostic error.
URS-003The system shall perform rule-based controls for: assay / content, purity and impurities, dissolution / disintegration, residual solvents, microbiology and pathogens, heavy metals / elemental impurities.HighEach controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML.
URS-004The system shall preserve traceability between batch/lot, source values, applied rules and final verdict.HighOutput includes batch identifier, source values, parameter statuses and critical findings.
URS-005The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review.HighJSON contains overall status, check array, warnings, failures and source-file reference.
URS-006The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks.HighThe document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval.
URS-007The system shall clearly separate technical data errors from specification nonconformities.MediumSchema/type errors are not mixed with pharmacopoeial deviations and are reported separately.

6. input.csv data contract

The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.

#ColumnTypeUnitDescriptionSampleControl rule
1BatchNumberidentifieras specifiedBatch NumberNIR-RIT-2026-001mandatory field; used for batch/lot traceability
2Nirmatrelvir_Assay_Percentdecimal%Nirmatrelvir Assay %100.5numeric value; compared with assay/purity limit from specification or method
3Nirmatrelvir_Oxidized_Impurity_Percentdecimal%Nirmatrelvir Oxidized Impurity %0.2numeric value; compared with individual or total impurity limit
4Nirmatrelvir_Hydrolysis_Impurity_Percentdecimal%Nirmatrelvir Hydrolysis Impurity %0.15numeric value; compared with individual or total impurity limit
5Ritonavir_Assay_Percentdecimal%Ritonavir Assay %101.0numeric value; compared with assay/purity limit from specification or method
6Ritonavir_Oxidized_Impurity_Percentdecimal%Ritonavir Oxidized Impurity %0.4numeric value; compared with individual or total impurity limit
7Ritonavir_Isomer_Impurity_Percentdecimal%Ritonavir Isomer Impurity %0.3numeric value; compared with individual or total impurity limit
8Total_Impurities_Percentdecimal%Total Impurities %1.0mandatory numeric value; rule comparison is performed by the utility
9Loss_On_Drying_Percentdecimal%Loss On Drying %0.4mandatory numeric value; rule comparison is performed by the utility
10Residual_Solvent_Toluene_ppmdecimalppmResidual Solvent Toluene ppm150numeric value; checked as residual solvent against the applicable limit
11Residual_Solvent_Dichloromethane_ppmdecimalppmResidual Solvent Dichloromethane ppm200numeric value; checked as residual solvent against the applicable limit
12Residual_Solvent_Acetonitrile_ppmdecimalppmResidual Solvent Acetonitrile ppm100numeric value; checked as residual solvent against the applicable limit
13Heavy_Metals_ppmdecimalppmHeavy Metals ppm5numeric value; checked as elemental/metal impurity
14Nirmatrelvir_Dissolution_30min_Percentdecimal%Nirmatrelvir Dissolution 30min %85.0numeric value; dissolution/disintegration profile checked according to method
15Ritonavir_Dissolution_30min_Percentdecimal%Ritonavir Dissolution 30min %80.0numeric value; dissolution/disintegration profile checked according to method
16Weight_Variation_RSDdecimalas specifiedWeight Variation RSD2.0mandatory numeric value; rule comparison is performed by the utility
17Friability_Percentdecimal%Friability %0.3mandatory numeric value; rule comparison is performed by the utility
18Microbial_Count_TAMCdecimalas specifiedMicrobial Count TAMC20numeric value; compared with microbiological limits
19Microbial_Count_TYMCdecimalas specifiedMicrobial Count TYMC5numeric value; compared with microbiological limits
20EColi_Detectedboolean / flag0/1EColi Detected0valid flag required; prohibited organisms and growth are normally expected as 0 / absent
21Salmonella_Detectedboolean / flag0/1Salmonella Detected0valid flag required; prohibited organisms and growth are normally expected as 0 / absent

CSV example

BatchNumber,Nirmatrelvir_Assay_Percent,Nirmatrelvir_Oxidized_Impurity_Percent,Nirmatrelvir_Hydrolysis_Impurity_Percent,Ritonavir_Assay_Percent,Ritonavir_Oxidized_Impurity_Percent,Ritonavir_Isomer_Impurity_Percent,Total_Impurities_Percent,Loss_On_Drying_Percent,Residual_Solvent_Toluene_ppm,Residual_Solvent_Dichloromethane_ppm,Residual_Solvent_Acetonitrile_ppm,Heavy_Metals_ppm,Nirmatrelvir_Dissolution_30min_Percent,Ritonavir_Dissolution_30min_Percent,Weight_Variation_RSD,Friability_Percent,Microbial_Count_TAMC,Microbial_Count_TYMC,EColi_Detected,Salmonella_Detected
NIR-RIT-2026-001,100.5,0.2,0.15,101.0,0.4,0.3,1.0,0.4,150,200,100,5,85.0,80.0,2.0,0.3,20,5,0,0

7. FS — functional specification

IDFunctionImplementation description
FS-001CLI entry pointThe executable NirmatrelvirRitonavirQualityChecker.exe supports demo mode and input.csv output.json processing mode.
FS-002CSV parserThe import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator.
FS-003Field conversionEach column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag.
FS-004Domain rule engineFor Nirmatrelvir Ritonavir, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check.
FS-005Criticality handlingCritical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS.
FS-006JSON writeroutput.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages.
FS-007Integration contractThe CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service.
FS-008Error handlingSchema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS.

8. output.json contract

The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.

{
  "utility": "NirmatrelvirRitonavirQualityChecker",
  "api": "Nirmatrelvir Ritonavir",
  "batchNumber": "NIR-RIT-2026-001",
  "overallStatus": "PASS|WARNING|FAIL",
  "checkedAtUtc": "2026-05-18T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "NIR-RIT-2026-001",
      "unit": "as specified",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Nirmatrelvir_Assay_Percent",
      "value": "100.5",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Nirmatrelvir_Oxidized_Impurity_Percent",
      "value": "0.2",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Nirmatrelvir_Hydrolysis_Impurity_Percent",
      "value": "0.15",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Ritonavir_Assay_Percent",
      "value": "101.0",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Ritonavir_Oxidized_Impurity_Percent",
      "value": "0.4",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Ritonavir_Isomer_Impurity_Percent",
      "value": "0.3",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Total_Impurities_Percent",
      "value": "1.0",
      "unit": "%",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": [],
  "sourceFile": "input.csv"
}

9. OQ/PQ test scenarios

IDScenarioExpected result
TC-001Valid CSV with expected header and sample rowAll rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail.
TC-002A mandatory input.csv column is missingImport is rejected or the row receives FAIL with schema reference.
TC-003A numeric field contains text or a blank valueType conversion error is recorded; the result is not hidden as PASS.
TC-004A parameter is outside specification or critical limitCritical parameters produce FAIL; non-critical deviations produce WARNING according to the rule.
TC-005Positive pathogen/microbiological flag or microbiological limit excursionCritical FAIL is produced with the offending parameter.
TC-006Insufficient dissolution or excessive disintegration timeFAIL/WARNING is produced according to method criticality.
TC-007Residual solvent above applicable limitFAIL is produced with solvent name and measured value.

10. QA/QC, CSV and change control

  • Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
  • Column names must not be changed without updating the validator and test scenarios.
  • The source CSV, output.json and utility version should be stored together as an evidence package.
  • Any change in control rules must go through change control and repeated OQ scenario verification.

Included in packages

Algeria: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Argentina: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Brazil: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

China: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Colombia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Egypt: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Iran: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Mexico: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Philippines: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Russia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Saudi Arabia: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Thailand: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Turkey: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

United States: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

Vietnam: national essential medicines QC package

QC utility package aligned with the country essential/reimbursed medicines list analogue and cross-checked against WHO EML. Only utilities already present in the portal are included; the package is a validation/discussion starting map, not an official registry copy.

Open

World API Extension QC Suite

Extended package for 130 additional high-demand APIs and biological products prepared as a market-coverage backlog.

Open